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Book Reviews
Principle Concepts of Technology and Innovation Management: Critical Research Models. By Robert S. Friedman, Desiree M. Roberts and Jonathan D. Linton, IGI Publishing, Hershey PA, 2008, ISBN 978-1605660387, hardback, US $165.00, pp. 322. This book is the result of an ambitious effort by the authors in providing a comprehensive reference guide to the theory and research supporting the field of technology and innovation management (TIM). The book offers both breadth and depth of coverage, which makes it a worthwhile reference source for the academic community and for practitioners in the field.
The broad field of TIM contains emergent boundaries as well as developing frameworks and theories. Interestingly the authors performed a citation analysis to identify the articles most referenced, and based on those results the key ideas of the articles were organized into thematic and subdisciplinary groupings that yielded the three major sections (comprising 11 chapters) of this book. The four appendices with the most cited papers and words also provide a helpful source of reference.
Section I of the book contains four chapters that are related by their foci on models and strategies for innovative product development and management processes. This section introduces the field of TIM and confirms that for those interested in innovation, they should be aware of the different perspectives that offer insights into the field of innovation like for example, psychology, economics, information sciences, management science, sociology, engineering, political science and history. Chapter 2 on 'R&D Process Models' deserves a mention here since this may be of particular interest to the R&D Management journal readership. The chapter highlights some articles that show how a firm's financial structure and ownership structure are found to be important to decisions regarding investment in R&D. This chapter also draws attention to the fact that the use and lack of use of various management science techniques by R&D managers has been of great importance in assisting theoreticians in better identifying the needs of R&D managers and the opportunities for the application of new and existing theory to the management of R&D.
Section II introduces the seminal literature on technological diffusion, product diversification, and organizational strategies and constraints that firms encounter when introducing and adopting new technologies and innovative management strategies. Knowledge transfer is a large subject addressed in this section, where the authors offer investigations into the reasons for and processes by which competing firms exchange organizational knowledge. Section II also provides an up to date reference source and this looks helpful for those who need to familiarize themselves with technological diffusion. Chapter 7 stresses that research from domains such as design, software engineering, and operations management can help with understanding how product architecture affects the performance of manufacturing firms. The examination of TIM presented in Section II captures well the message conveyed throughout this book that a single 'best practice' approach to managing technology and innovation in firms is not possible. Approaches to managing innovation need to be linked to particular purposes, knowledge processes, and enabling contexts. The tendency to neglect these linkages reflects a still quite deeply entrenched assumption that there is a relatively straightforward and positive relationship between knowledge, innovation and performance outcomes.
Section III starts with Chapter 9 'Information and Communication Technology Management', where the authors retain a chronological order to emphasize the development of research interests and approaches as technology itself grows more complex, sophisticated, and increasingly integral to a firm's innovative ends and operative strategies. This section then goes onto highlight key theoretical contributions to the area of open source and software development innovation in Chapter 10, before finishing with some conclusions on the directions the field of TIM is taking in the final chapter of the book.
Finally, it is worth noting that the book authors have identified areas that they consider to be trendsetters for future research in TIM, which are listed as: NPD, supply chains, network or relationship-related concepts, and new emphasis and approaches to technology transfer research. This book is one of the very few contributions that attempt to analyse the different subfields of TIM as a multi-discipline academic subject. The authors are to be commended for providing a concise discussion of the seminal work in the top subfields of this rapidly growing area. In Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry; i.e there is an immense gap between the US$48 billion invested annually by US and EU pharmaceutical industries, complemented with similar amounts in academic research and the productivity of just 17 new medical entities approved by the FDA in 2007 (FitzGerald, 2008) .
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This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems that may not be obvious to an MD, PhD or business economists entering this industry at first hand.
In an initial chapter the authors actually pose the question, if one wishes to be in this industry at all? The impression one could get on the likelihood for starting a successful career or enterprise in this industry for future orientation, could be quite gloomy. In fact, if one of the reviewers of this work, Thomas Wilckens, had read such a book 12 years earlier, he would have possibly never engaged in starting a drug discovery company given the vanishing small chances of success. This retrospective analysis that converges with the conclusion that the venture-capital driven biotechnology drug discovery concept was condemned to fail (Pisano, 2006) , is corroborated by the fact that most late stage drug development failures account to solely biotech company projects. However, any experience including the 'biotech hype' creates value, if appropriately analysed and incorporated in the creation of new, innovative value creation concepts.
In this context, Gassmann and colleagues address essential factors that contribute to lack of innovation and describe them in different sections. Importantly, Gassmann and colleagues highlight additional incentives that derives from working in the pharmaceutical industries addressing medical need, although a critical analysis of managerial errors, where mergers served shareholder value, but irretrievably destroyed essential research capabilities is missing. The fact, that the lifecycle of a product to hit the market is longer (i.e. up to 10 years) than that of most senior executives, is not addressed as a potential problem that leads to an awkward incentivisation for senior management under pressure to serve the shareholders interest. Also, discussions on market needs do not address complex challenges in any detail, like the paradox that the industry suffers from an image problem of being too opportunistic and market-driven.
This book provides most valuable insight into the pharmaceutical industry from an 'outsiders' perspective. However, there appears to be little attention paid to analysis of industry-specific organisational or technical discussions including emerging concepts like translational sciences, which is not really well defined, but appears central to establish novel value creation concepts to bridge the innovation gap (FitzGerald, 2008) . Chapter V for example gives an outlook on resources for R&D that also comprises globalisation and competition amongst academic institutions worldwide, while Chapter VI describes managerial approaches that have been recently adopted at some companies to address the 'innovation gap'.
